SCHEMBL7149083

SCHEMBL7149083

COC(OC)(C(Cn1cccc1)P(O)(O)(O)CC(C#N)N(C(C)C)C(C)C)C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7149012 0.88 TSHR (0.35)
SCHEMBL7146592 0.82 CYP1A2 (0.35)
SCHEMBL7144825 0.81 TK1 (0.42)
SCHEMBL7149316 0.78 KDM4E (0.39)
SCHEMBL7139055 0.77
SCHEMBL7147277 0.76 PARP14 (0.30)
SCHEMBL8729507 0.74
SCHEMBL7620791 0.68 HTT (0.33)
SCHEMBL7142477 0.68 CTSS (0.32)
SCHEMBL7150130 0.67 CTSS (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065146-A1 Monomeric diols, phosphate linked oligomers formed therefrom and processes for preparing COOK PHILLIP D (US) 2003-04-03 US disclosed
US-6448373-B1 INHIBITORS OF ENZYMES SUCH AS PHOSPHOLIPASE A2; TREATMENT OF INFLAMMATORY DISEASES INCLUDING ATOPIC DERMATITIS AND INFLAMMATORY BOWEL DISEASE ISIS PHARMACEUTICALS, INC. 2002-09-10 US disclosed
EP-0739351-B1 MONOMERIC DIOLS AND PHOSPHATE LINKED OLIGOMERS FORMED THEREFROM ISIS PHARMACEUTICALS INC (US) 2002-04-10 EP disclosed